Table 2.
NIPD approaches implemented for determining fetal genotype in beta-thalassemia
|
| ||||
| Author, year (Ref) | Mutations | Methods | Sens. | Spec. |
| Li et al. , 2005 (49) | IVSI-1, IVSI-6, IVSI-110, and codon 39 (compound heterozygote) | Peptide-nucleic-acid clamp and allele-specific real-time PCR | 100 | 93.8 |
| Galbiati et al. , 2016 (39) | Cd39 and IVSI.110 | COLD-PCR and microarray | 100 | 100 |
| Mortazavipour et al. , 2020 (48) | IVSII-1 | COLD-PCR | NA | |
| Phylipsen et al. , 2012 (50) | 12 different fragments along with the β-globin gene cluster | PAP and MCA | NI | |
| Papasavva et al. , 2008 (51) | 11 SNPs | APEX method | NI | |
| Yi et al. , 2010 (52) | IVSII-654 (C T) | PCR/LDR/capillary electrophoresis | NI | |
| Yi et al. , 2010 (53) | CD17 (A T) | PCR/LDR/capillary electrophoresis | 1:5000 | NI |
| Chiu et al. , 2002 (54) | 41/42 (–CTTT) | Real-time PCR | 100 | 100 |
| Lun et al. , 2008 (44) | CD41/42 (–CTTT ) | RMD & NASS | NI | |
| Li et al. , 2009 (55) | Cd39 | Mutation-specific PCR & MALDI TOF | NA | |
| Ramezanzadeh et al. , 2016 (56) | CD44, IVSI-1, FR8-9, and IVSI-5 | Allele-specific real-time PCR | 100 | 100 |
| Wang et al. , 2017 (45) | CD41-42 (-TTCT) | RHD | 100 | 100 |
| Camunas-Soler et al. , 2018 (22) | Droplet digital PCR (RMD) | 99.8 | 99.8 | |
| Chan et al. , 2010 (57) | 4 SNPs in connection with HBB gene | AS-APEX | 100 | 100 |
| Byrou et al. , 2018 (38) | 2 SNPs (rs7480526 and rs968857) | Fast TG COLD- PCR | NA | |
| Yenilmez et al. , 2013 (46) | Used 4 primers: P1:Cap +22 (G A) and-30 (C T) P2: IVSI-1 (G A), IVSI-5 (G A), IVSI-6 (T C), IVSI-110, (G A), Cd8 ( AA), Cd9/10 (+T), Cd15 (G A), and Cd39 (C T) P3: IVSII-1 (G A) P4: IVSII-745 (C G) and IVSII-848 (C A) | HRM | 100 | 100 |
| Saba et al. , 2017 (47) | c.118C4T | Semiconductor sequencing | 100 | 100 |
| Lam et al. , 2012 (29) | Cd41/42, 28(A G), and CD17 | MPS | 100 | 100 |
| NIPD: Non-invasive prenatal diagnosis, Spec: Specificity (%), Sens: Sensitivity (%), NA: Not applicable, NI: Not indicated, PAP: Pyrophosphorolysis-activated polymerization, MCA: Melting curve analysis, SNPs: Single nucleotide polymorphisms, LDR: Ligase detection reaction, NASS: Nucleic acid size selection, MALDI TOF: Matrix assisted laser desorption ionization time of flight, RMD: Relative mutation dosage, RHD: Relative haplotype dosage, AS: Allele specific, APEX: Arrayed primer extension, TG COLD-PCR: Temperature gradient coamplification at lower denaturation temperature PCR, HRM: High resolution melting, MPS: Massively parallel sequencing, PCR: Polymerase chain reaction | ||||